摘要
目的探讨何种方案治疗支原体肺炎更有效、更经济。方法将87例患者分为3组:红霉素组、阿奇霉素组和联合用药组,分析其临床疗效。结果红霉素组发热缓解时间最短,阿奇霉素组和联合用药组肺部罗音消失时间较短,而联合用药组住院时间最短,所需费用最少(P<0.01)。结论无论从药代动力学还是从临床疗效来分析,红霉素和阿奇霉素联合治疗支原体肺炎更有效、经济和安全。
Objective In the study,three therapeutics were used to explore a method to more effectively treat mycoplasma pneumonia.Methods 87 cases were divided into three groups:the erythromycin group,the azithromycin group and the drug combination group.Subsequently,their clinical curative effects were analyzed.Results The results revealed that the antipyrefic time was the shortest in the erythromycin group.The time of lung rales disappearance was the shorter in the azithromycin and the combination group.In the drug combination group,patients stayed in hospital most shortest with the least cost.In conclusion.Conclusion No matter analysis from pharmaco kinetics or clinical curative effect,the therapeutic of drug combination of the erythromycin and azithromycin to treat mycoplasma pneumonia was more effective,economic and safe.
出处
《中国实用医药》
2007年第9期33-34,共2页
China Practical Medicine
关键词
支原体肺炎
红霉素
阿奇霉素
mycoplasma pneumonia
erythromycin
azithromycin
